• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同系物和杂系物的三价铋羧酸盐的抗利什曼原虫活性。

Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates.

机构信息

School of Chemistry, Monash University, Clayton, Melbourne, Victoria, Australia.

出版信息

J Inorg Biochem. 2011 Mar;105(3):454-61. doi: 10.1016/j.jinorgbio.2010.08.007. Epub 2010 Aug 19.

DOI:10.1016/j.jinorgbio.2010.08.007
PMID:20851471
Abstract

Bismuth(III) complexes of NSAIDs (Non-Steroidal Anti Inflammatory Drugs) and substituted benzoic acids (o-methoxybenzoic acid, m-methoxybenzoic acid, o-nitrobenzoic acid, 3,5-diacetamidobenzoic acid, and 5-[(R/S)-2,3-dihydroxypropyl carbamoyl]-2-pyridine carboxylic acid) have been synthesised and fully characterised. Two new bis-carboxylato bismuth complexes have been characterised by single crystal X-ray diffraction, namely [PhBi(o-MeOC(6)H(4)CO(2))(2)(bipy)]·0.5EtOH (bipy=2,2'-bipyridine) and [PhBi(C(9)H(11)N(2)O(3)CO(2))(2)(H(2)O)]·6H(2)O. All compounds were tested against the parasite Leishmania major promastigotes for their anti-Leishmanial activity and were further assessed for their toxicity to mammalian cells. The NSAID free acids and their bismuth derivatives show negligible anti-Leishmanial activity at concentrations 1.95 to 250 μg/mL against the promastigotes of L. major whereas in the case of mammalian cells only bismuth complexes of naproxen and mefenamic acid have significant effect at concentration≥250 μg/mL. The bismuth(III) complexes of substituted benzoic acids show significant anti-Leishmanial activity against the promastigotes of L. major V121 at very low concentrations while their respective free carboxylic acids show no effective activity. However, the bismuth compounds inhibit the growth of the mammalian cells at all concentrations studied (1.95 to 500 μg/mL) following 48 h incubation. The comparatively low toxicity of BiCl(3) and Bi(NO(3))(3), suggests that overall toxicity of bismuth complexes towards the parasite is both ligand and metal dependent.

摘要

已合成并充分表征了 NSAIDs(非甾体抗炎药)和取代苯甲酸(邻甲氧基苯甲酸、间甲氧基苯甲酸、邻硝基苯甲酸、3,5-二乙酰氨基苯甲酸和 5-[(R/S)-2,3-二羟基丙基氨甲酰基]-2-吡啶羧酸)的三价铋配合物。通过单晶 X 射线衍射对两种新的双羧基铋配合物进行了表征,即[PhBi(o-MeOC6H4CO2)2(bipy)]·0.5EtOH(bipy=2,2'-联吡啶)和[PhBi(C9H11N2O3CO2)2(H2O)]·6H2O。所有化合物均针对寄生虫利什曼原虫的前鞭毛体进行了抗利什曼原虫活性测试,并进一步评估了它们对哺乳动物细胞的毒性。在浓度为 1.95 至 250μg/mL 时,游离 NSAID 和它们的铋衍生物对利什曼原虫前鞭毛体几乎没有抗利什曼原虫活性,而对于哺乳动物细胞,只有游离萘普生和甲芬那酸的铋复合物在浓度≥250μg/mL 时才有显著作用。取代苯甲酸的铋(III)配合物对利什曼原虫 V121 的前鞭毛体表现出显著的抗利什曼原虫活性,而它们各自的游离羧酸则没有有效活性。然而,在 48 小时孵育后,所有研究浓度(1.95 至 500μg/mL)的铋化合物均抑制了哺乳动物细胞的生长。BiCl3 和 Bi(NO3)3 的相对低毒性表明,铋配合物对寄生虫的总体毒性既依赖于配体又依赖于金属。

相似文献

1
Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates.同系物和杂系物的三价铋羧酸盐的抗利什曼原虫活性。
J Inorg Biochem. 2011 Mar;105(3):454-61. doi: 10.1016/j.jinorgbio.2010.08.007. Epub 2010 Aug 19.
2
Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.三价铋β-硫代酮配合物作为抗幽门螺杆菌抗生素和抗利什曼原虫药物。
Dalton Trans. 2014 Jan 21;43(3):1279-91. doi: 10.1039/c3dt52544a. Epub 2013 Nov 5.
3
Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.铋(III)α-羟基羧酸盐:乙醇酸盐对硕大利什曼原虫的高度选择性毒性。
J Biol Inorg Chem. 2015 Oct;20(7):1193-203. doi: 10.1007/s00775-015-1299-6. Epub 2015 Sep 28.
4
Stability and toxicity of tris-tolyl bismuth(V) dicarboxylates and their biological activity towards Leishmania major.三芳基铋(V)二羧酸盐的稳定性、毒性及其对硕大利什曼原虫的生物活性
Dalton Trans. 2015 Nov 7;44(41):18215-26. doi: 10.1039/c5dt03335g. Epub 2015 Oct 1.
5
Structural motifs in phenylbismuth heterocyclic carboxylates--secondary interactions leading to oligomers.苯并铋杂环羧酸酯中的结构基序 - 导致低聚物的次级相互作用。
Dalton Trans. 2012 Jan 21;41(3):1004-12. doi: 10.1039/c1dt11207d. Epub 2011 Nov 21.
6
Stability and toxicity of heteroleptic organometallic Bi(V) complexes towards Leishmania major.杂配有机金属铋(V)配合物对硕大利什曼原虫的稳定性和毒性
Dalton Trans. 2014 Sep 14;43(34):12904-16. doi: 10.1039/c4dt00957f.
7
Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.结构对三价铋与吲哚羧酸配合物抗幽门螺杆菌和利什曼原虫活性的影响。
J Inorg Biochem. 2017 Dec;177:266-275. doi: 10.1016/j.jinorgbio.2017.05.014. Epub 2017 May 31.
8
Synthetic and structural comparisons of bismuth(III) carboxylates synthesised under solvent-free and reflux conditions.在无溶剂和回流条件下合成的铋(III)羧酸盐的合成及结构比较
Dalton Trans. 2006 Oct 28(40):4852-8. doi: 10.1039/b605002f. Epub 2006 Aug 23.
9
Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).抗氧化剂、体外、体内抗炎活性和消炎痛及其与锰(II)、钴(II)、镍(II)、铜(II)和锌(II)的金属配合物的增殖活性。
J Enzyme Inhib Med Chem. 2009 Jun;24(3):742-52. doi: 10.1080/14756360802361589.
10
Bismuth(III) 5-sulfosalicylate complexes: structure, solubility and activity against Helicobacter pylori.铋(III)5-磺基水杨酸盐配合物:结构、溶解性及对幽门螺杆菌的活性
Dalton Trans. 2009 Aug 28(32):6377-84. doi: 10.1039/b900774a. Epub 2009 Jun 25.

引用本文的文献

1
Bismuth drug eradicates multi-drug resistant complex aerobic respiration.铋剂药物根除多重耐药的复杂有氧呼吸。
Chem Sci. 2025 May 9. doi: 10.1039/d5sc02049b.
2
A Second Wind for Inorganic APIs: Leishmanicidal and Antileukemic Activity of Hydrated Bismuth Oxide Nanoparticles.无机活性药物成分的新活力:水合氧化铋纳米颗粒的抗利什曼原虫和抗白血病活性
Pharmaceutics. 2024 Jun 29;16(7):874. doi: 10.3390/pharmaceutics16070874.
3
Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?生物活性铋化合物:它们的毒性是否成为治疗应用的障碍?
Int J Mol Sci. 2024 Jan 27;25(3):1600. doi: 10.3390/ijms25031600.
4
Biological Activities of Bismuth Compounds: An Overview of the New Findings and the Old Challenges Not Yet Overcome.铋化合物的生物学活性:新发现综述及尚未克服的旧挑战。
Molecules. 2023 Aug 7;28(15):5921. doi: 10.3390/molecules28155921.
5
novel responses to Bi-doped strontium aluminum oxyfluorides.对掺铋氟氧化锶铝的新型响应
Heliyon. 2021 Aug 30;7(9):e07896. doi: 10.1016/j.heliyon.2021.e07896. eCollection 2021 Sep.
6
Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.铋(III)α-羟基羧酸盐:乙醇酸盐对硕大利什曼原虫的高度选择性毒性。
J Biol Inorg Chem. 2015 Oct;20(7):1193-203. doi: 10.1007/s00775-015-1299-6. Epub 2015 Sep 28.
7
Current and potential applications of bismuth-based drugs.铋基药物的当前及潜在应用
Molecules. 2014 Sep 23;19(9):15258-97. doi: 10.3390/molecules190915258.
8
Activity of antifungal organobismuth(III) compounds derived from alkyl aryl ketones against S. cerevisiae: comparison with a heterocyclic bismuth scaffold consisting of a diphenyl sulfone.源自烷基芳基酮的抗真菌有机铋(III)化合物对酿酒酵母的活性:与由二苯砜组成的杂环铋支架的比较。
Molecules. 2014 Jul 29;19(8):11077-95. doi: 10.3390/molecules190811077.
9
Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages.新型三苯基锑(V)和三苯基铋(V)与苯甲酸衍生物的配合物:结构表征、体外抗利什曼原虫和抗菌活性以及对巨噬细胞的细胞毒性
Molecules. 2014 May 12;19(5):6009-30. doi: 10.3390/molecules19056009.
10
Performance assessment of semiempirical molecular orbital methods in the structural prediction of Sb(III) and Bi(III) complexes.半经验分子轨道方法在 Sb(III)和 Bi(III)配合物结构预测中的性能评估。
J Mol Model. 2013 Oct;19(10):4575-84. doi: 10.1007/s00894-013-1974-x.